Astrana Health Inc.
ASTH
Positions held
Your positionsASTH isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Astrana Health Inc. is well-positioned in the healthcare sector with a strong revenue growth of 48.5% year-over-year, indicating robust demand for its medical care facilities.
- Revenue increased by 1% compared to the prior quarter, reaching $973 million.
- The company has a strong buy recommendation with a target mean price of $51.67.
- Despite growth, Astrana Health has a high trailing P/E ratio of 44.58, which may indicate overvaluation compared to industry peers.
- The operating margin has declined to 3.53% in the latest quarter from 4.39% in the previous year.
- The debt-to-equity ratio stands at 163.62, suggesting high leverage which could pose risks in a downturn.
Fundamentals
| Market cap | $1.78B | Enterprise value | $2.18B | Trailing P/E | 43.22 | Forward P/E | 9.86 |
| PEG | — | Price / book | 2.13 | Beta | 1.03 | Dividend yield | 0.00% |
| Revenue growth | 48.5% | Earnings growth | 110.5% | Gross margin | 10.5% | Operating margin | 3.5% |
| Profit margin | 1.1% | ROE | 6.9% | ROA | 3.8% | Debt / equity | 1.64 |
| Current ratio | 1.23 | Free cash flow | $231.19M | Analyst recommendation | strong_buy | Mean target | $51.67 |
| 52w high | $51.60 | 52w low | $18.08 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $973M | $965M | $951M | $956M | $655M |
| Op margin | 3.5% | 3.0% | 1.9% | 2.0% | 3.1% |
| Net income | $19.7M | $14.4M | $6.0M | $0.4M | $9.4M |
| Gross margin | 10.7% | 11.0% | 10.0% | 10.2% | 11.9% |
| Gross profit | $104M | $106M | $95.0M | $97.2M | $78.0M |
| Operating income | $34.3M | $28.5M | $18.4M | $19.2M | $20.3M |
- Revenue +1% vs prior quarter ($973M vs $965M).
- Gross margin 10.7% (was 11% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.2B | $2.0B | $1.4B | $1.1B | — |
| Op margin | 2.5% | 4.4% | 6.1% | 9.1% | — |
| Net income | $22.5M | $43.1M | $60.7M | $45.2M | — |
| Gross margin | 10.7% | 13.3% | 15.5% | 17.4% | — |
| Gross profit | $342M | $271M | $215M | $199M | — |
| Operating income | $78.5M | $89.3M | $84.6M | $104M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Astrana Health (ASTH): Buy, Sell, or Hold Post Q2 Earnings?
2026-10-07 · Why Alignment Healthcare (ALHC) Stock Is Up Today
2026-10-07 · Alignment Healthcare Introduces Its Medicare Advantage Plan to Three New California Counties
2026-09-30 · Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
2026-09-23 · Sector Update: Healthcare Stocks Decline Late Afternoon
2026-09-23 · Why Astrana Health (ASTH) Shares Are Trading Lower Today
2026-09-23 · Sector Update: Healthcare Stocks Retreat in Afternoon Trading
2026-09-23 · Sector Update: Healthcare
2026-09-23 · Astrana Health Reports Material Cyberattack; Shares Fall Pre-Bell
2026-09-17 · Sector Update: Healthcare Stocks Rise Thursday Afternoon
2026-09-17 · Astrana Health Shares Fall After GlassHouse Research Publishes Short-Seller Report
2026-09-15 · Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
Price (daily)
Full chart · RSI · MACD · patterns